Results 21 to 30 of about 13,793,115 (299)

Pharmacovigilance as an imperative of modern medicine - experience from Montenegro [PDF]

Vojnosanitetski Pregled, 2017
nema
Mugoša Snežana, Stanković Maja, Turković Nemanja, Šahman-Zaimović Majda, Bešović Željka, Drljević Milorad   +5 more
doaj   +1 more source

Suspected Adverse Drug Reactions in Pediatric Cancer Patients in China: An Analysis of Henan Province Spontaneous Reporting System Database

Frontiers in Oncology, 2021
IntroductionAdverse drug reactions (ADRs) in pediatric cancer patients have not yet received due attention in the world. Antineoplastic drugs are frequently related to ADRs.
Zhiming Jiao, Zhanchun Feng, Ziqi Yan, Jinwen Zhang, Gang Li, Ganyi Wang, Ganyi Wang, Qianyu Wang, Da Feng   +8 more
doaj   +1 more source

Improving reporting of adverse drug reactions: Systematic review. [PDF]

, 2009
BACKGROUND: Adverse drug reactions (ADRs) are a significant cause of morbidity and mortality, with many being identified post-marketing. Improvement in current ADR reporting, including utility of underused or innovative methods, is crucial to improve ...
Molokhia, Mariam, Mariam Molokhia, Tanna, S, Molokhia, M, Bell, D, Bell, Derek, Derek Bell, Tanna, Shivani, Shivani Tanna   +8 more
core   +1 more source

Evaluation of patient reporting of adverse drug reactions to the UK ‘Yellow Card Scheme’: literature review, descriptive and qualitative analyses, and questionnaire surveys [PDF]

, 2011
Background: The monitoring of adverse drug reactions (ADRs) through pharmacovigilance is vital to patient safety. Spontaneous reporting of ADRs is one method of pharmacovigilance, and in the UK this is undertaken through the Yellow Card Scheme (YCS ...
DJ McLernon, Murphy, E., Fortnum, H, Watson, M C, McLernon, D.J., Hazell, L, Gifford, A., MC Watson, Fortnum, H., Watson, M.C., Bond, C. M., Lee, A.J., Avery, A J, Bond, Christine, Hannaford, P.C., Krska, Janet, Watson, M. C., Avery, Anthony, J Krska, Krska, J, Mclernon, David J., Hannaford, P C, Shakir, S., Lee, A J, Lee, A. J., Gifford, A, Murphy, E, CM Bond, E Murphy, L Hazell, Hazell, L., Gifford, Alison, Watson, Margaret C., A Gifford, H Fortnum, AJ Avery, Bond, C.M., C Anderson, Anderson, C., Anderson, C, S Shakir, McLernon, D. J., McLernon, D J, Anderson, Claire, Bond, C M, Fortnum, Heather, Shakir, S, Avery, A. J., PC Hannaford, Murphy, Elizabeth, Hannaford, P. C., Hannaford, Philip C., AJ Lee, Krska, J.   +53 more
core   +1 more source

Enhancing Communication about Paediatric Medicines: Lessons from a Qualitative Study of Parents' Experiences of Their Child's Suspected Adverse Drug Reaction [PDF]

, 2012
Background: There is little research on parents' experiences of suspected adverse drug reactions in their children and hence little evidence to guide clinicians when communicating with families about problems associated with medicines.
Smyth, RL, Young, B., Hesselgreaves, H, Munir Pirmohamed (40546), Janine Arnott (128747), Turner, M.A., Anthony J Nunn, Rosalind L. Smyth (80205), Mark A. Turner (114089), Hesselgreaves Hannah, Nunn, Anthony J., Nunn Anthony J., Nunn, Anthony J, Turner, Mark A, Matthew Peak (114087), Hesselgreaves, H., Pirmohamed, Munir, Nunn, AJ, Pirmohamed, M, Peak, M, Munir Pirmohamed, Smyth Rosalind L., Janine Arnott, Arnott Janine, Pirmohamed Munir, Nunn, A.J., Hannah Hesselgreaves (128748), Peak, M., Bridget Young (128749), Hannah Hesselgreaves, Bridget Young, Anthony J. Nunn (114088), Young, Bridget, Matthew Peak, Arnott, J, Turner Mark A., Turner, MA, Young, B, Rosalind L Smyth, Pirmohamed, M., Smyth, Rosalind L., Hesselgreaves, Hannah, Mark A Turner, Smyth, Rosalind L, Arnott, Janine, Young Bridget, Peak Matthew, Arnott, J., Smyth, R.L., Peak, Matthew, Turner, Mark A.   +50 more
core   +1 more source

Suspected Adverse Drug Reactions Related to Breast Cancer Chemotherapy: Disproportionality Analysis of the Brazilian Spontaneous Reporting System

Frontiers in Pharmacology, 2019
Spontaneous reporting systems may generate a large volume of information in real world conditions with a relatively low cost. Disproportionality measures are useful to indicate and quantify unexpected safety issues associated with a given drug-event pair
Flávia Campos Barcelos, Guacira Corrêa de Matos, Mario Jorge Sobreira da Silva, Fabrício Alves Barbosa da Silva, Elisangela da Costa Lima   +4 more
doaj   +1 more source

Heuristic Evaluation of adverse drug reaction reporting System

, 2023
Abstract Background Adverse drug reactions as an ongoing public health issue, affects various aspects of society. This study aims to conduct a comprehensive study of usability and to evaluate usability of National Adverse Drug Reactions Reporting System. Methods This study was descriptive and cross-sectional.
Marziyhe Meraji, Haniyeh Bameri, Zahra Ebnehoseini, Nahid Ramezanghorbani   +3 more
openaire   +1 more source

Torsadogenic risk of antipsychotics : combining adverse event reports with drug utilization data across Europe [PDF]

, 2013
Antipsychotics (APs) have been associated with risk of torsade de Pointes (TdP). This has important public health implications. Therefore, (a) we exploited the public FDA Adverse Event Reporting System (FAERS) to characterize their torsadogenic profile; (
Kalaba, Marija, Barbui, Corrado, Koci, Ariola, Sturkenboom, Miriam, Moretti, Ugo, Godman, Brian, Bennie, Marion, Raschi, Emanuel, Wettermark, Bjorn, Poluzzi, Elisabetta, De Ponti, Fabrizio   +10 more
core   +3 more sources

Delayed angioedema during therapy with angiotensin-converting enzyme inhibitors [PDF]

Vojnosanitetski Pregled, 2011
Introduction. Angiotensin-converting enzyme inhibitors are leading cause of drug-induced angioedema, with incidence of 0.1 to 0.2%. The angioedema is not of immune nature; in predisposed individuals it is caused by accumulation of vasoactive mediators
Janković Slobodan M., Stefanović Srđan M.   +1 more
doaj   +1 more source

Potential kidney damage associated with the use of remdesivir for COVID-19: analysis of a pharmacovigilance database

Cadernos de Saúde Pública, 2021
: The U.S. Food and Drug Administration (FDA) has stated that the prescription of remdesivir should be cautious for patients with estimated glomerular filtration rate (eGFR) < 30 and some studies reported risk of adverse renal events.
Nayara Aparecida de Oliveira Silva, Ana Laura de Sene Amâncio Zara, Albert Figueras, Daniela Oliveira de Melo   +3 more
doaj   +1 more source